# OnCo record nct07386938 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07386938/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07386938", "NCT07386938" ;
  schema:name "A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer"@en ;
  schema:description "A phase 3 trial testing RPH-051 in HR-positive / HER2-negative breast cancer and HER2-positive breast cancer, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07386938/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07386938> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2024-08-09" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:drugs <https://onco.cc/drugs/rph-051/> ;
  onco:companies <https://onco.cc/companies/r-pharm/> .